| Primary |
| Muscle Spasticity |
79.9% |
| Product Used For Unknown Indication |
12.0% |
| Pain |
2.0% |
| Spasticity |
0.9% |
| Cerebral Palsy |
0.6% |
| Muscle Spasms |
0.6% |
| Antidepressant Therapy |
0.3% |
| Bladder Spasm |
0.3% |
| Confusional State |
0.3% |
| Convulsion |
0.3% |
| Delusion |
0.3% |
| Friedreich's Ataxia |
0.3% |
| Headache |
0.3% |
| Hypertension |
0.3% |
| Insomnia |
0.3% |
| Movement Disorder |
0.3% |
| Nasopharyngitis |
0.3% |
| Paraparesis |
0.3% |
| Spinal Cord Injury |
0.3% |
| Stiff Person Syndrome |
0.3% |
|
| Muscle Spasticity |
13.0% |
| Withdrawal Syndrome |
12.0% |
| Infection |
11.5% |
| Underdose |
9.5% |
| Urinary Tract Infection |
6.5% |
| Drug Withdrawal Syndrome |
5.0% |
| Pyrexia |
5.0% |
| Death |
4.5% |
| Overdose |
4.5% |
| Pruritus |
4.5% |
| Pain |
3.5% |
| Muscle Tightness |
3.0% |
| Musculoskeletal Stiffness |
2.5% |
| Unresponsive To Stimuli |
2.5% |
| Vomiting |
2.5% |
| Drug Ineffective |
2.0% |
| Implant Site Erosion |
2.0% |
| Implant Site Infection |
2.0% |
| Psychotic Disorder |
2.0% |
| Sepsis |
2.0% |
|
| Secondary |
| Muscle Spasticity |
53.7% |
| Product Used For Unknown Indication |
27.6% |
| Cerebral Palsy |
3.7% |
| Pain |
2.2% |
| Antidepressant Therapy |
1.5% |
| Bladder Spasm |
1.5% |
| Hypertension |
1.5% |
| Muscle Spasms |
1.5% |
| Supplementation Therapy |
1.5% |
| Confusional State |
0.7% |
| Delusion |
0.7% |
| Friedreich's Ataxia |
0.7% |
| Headache |
0.7% |
| Nasopharyngitis |
0.7% |
| Paraparesis |
0.7% |
| Stiff Person Syndrome |
0.7% |
|
| Muscle Spasticity |
11.9% |
| Urinary Incontinence |
11.9% |
| Pyrexia |
8.5% |
| Withdrawal Syndrome |
8.5% |
| Underdose |
6.8% |
| Urinary Tract Infection |
6.8% |
| Vomiting |
6.8% |
| Pseudomeningocele |
5.1% |
| Somnolence |
5.1% |
| Vision Blurred |
5.1% |
| Cerebrospinal Fluid Leakage |
3.4% |
| Mental Status Changes |
3.4% |
| Musculoskeletal Stiffness |
3.4% |
| Nausea |
3.4% |
| Drug Withdrawal Syndrome |
1.7% |
| Intervertebral Disc Injury |
1.7% |
| Medical Device Complication |
1.7% |
| Migraine |
1.7% |
| Muscle Rigidity |
1.7% |
| Muscle Spasms |
1.7% |
|
| Concomitant |
| Muscle Spasticity |
66.7% |
| Multiple Sclerosis |
33.3% |
|
|
